10.1038/s41598-020-63759-1 - Clinical outcome of breast cancer in ...

This document has been corrected

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

10.1038/s41598-020-63759-1

Published Online: 2020-04-27

Journal: Scientific Reports•Publisher: Springer Science and Business Media LLC

Authors: Adrien Buisson•Alex Friedlaender•Alexandre Bodmer•Aurelie Vuilleumier•Aurélie Ayme•Christine Lasset•Isabelle Treilleux•Jean- Christophe Tille•Julien Peron•Noemie Lang•Olivier Trédan•Pierre O. Chappuis•S.Intidhar Labidi-Galy•Solene De Talhouet•Sophie Giraud•Valeria Viassolo•Valerie Bonadona

This document has been corrected

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

10.1038/s41598-020-63759-1

Published Online: 2020-04-27

Journal: Scientific Reports

NOW

2020-11-02•Correction

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

10.1038/s41598-020-76385-8

* information provided by CrossRef

2020-11-02•Correction

10.1038/s41598-020-76385-8

* information provided by CrossRef

2020-04-27•Published

2020-11-02•Correction

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

10.1038/s41598-020-76385-8

* information provided by CrossRef

This document has been corrected

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

10.1038/s41598-020-63759-1

Published Online: 2020-04-27

Journal: Scientific Reports•Publisher: Springer Science and Business Media LLC